Kuehne+Nagel delivers first 215,000 doses of Sinovac vaccine to Ukraine

Kuehne+Nagel Sinovac

Kuehne+Nagel has delivered the first batch of CoronaVac vaccine produced by Sinovac Biotech Ltd., a leading biopharmaceutical company in China. Kuehne+Nagel, therefore, is the first logistics company to deliver the Chinese Covid-19 vaccine to Ukraine. The shipment is part of a global agreement between the two companies.

Kuehne+Nagel delivered the first 215,000 doses of CoronaVac at the end of March 2021. The cargo was transported by air from Beijing in special active cooling containers. At all stages of transport, Kuehne+Nagel maintained product integrity at the required temperature of +2 to +8°C. At the end of February, Kuehne+Nagel successfully helped Sinovac fulfill its first Covid-19 vaccine shipment to the Dominican Republic.

“Kuehne Nagel has actively expanded its GxP-certified pharma network over the past few years. We are ready to support the global fight against the pandemic by delivering medicines and vaccines as soon as possible and in compliance with the required temperature regime,” says Andrii Savka, National Air Logistics Manager, Kuehne+Nagel Ukraine.

According to the office of the President of Ukraine and the Ministry of Health, the overall contract with Sinovac Biotech encompasses 1.9 million doses of vaccine. Thus, this first delivery of CoronaVac to Ukraine marks the start of large-scale work to overcome the pandemic in the country.

อัพเดตข่าวสารและบทความที่น่าสนใจในอุตสาหกรรมโลจิสติกส์ก่อนใคร ผ่าน Line Official Account @Airfreight Logistics เพียงเพิ่มเราเป็นเพื่อน @Airfreight Logistics หรือคลิกที่นี่